Department of Anesthesiology, Columbia University Medical Center, New York, NY.
J Neurosurg Anesthesiol. 2019 Jan;31(1):103-107. doi: 10.1097/ANA.0000000000000538.
On April 14 and 15, 2018, the Sixth Biennial Pediatric Anesthesia Neurodevelopmental Assessment (PANDA) Symposium convened at Columbia University Medical Center and New York Presbyterian/Morgan Stanley Children's Hospital of New York. Since its inception over 10 years ago, the PANDA Symposium has served as a key forum for clinicians, researchers, and other major stakeholders to gather and review the current state of preclinical and clinical research related to anesthetic neurotoxicity in the developing brain. It has also served as an important venue for participants to gain insight and leverage support from various public and private regulatory bodies. Goals of this year's meeting included assessments of how current knowledge has evolved, endeavors to develop common outcome measures, and formulations of future directions for research and policy. The Symposium program highlighted a diverse body of cutting-edge work, from results of preclinical and clinical studies to updates in clinical practice and policymaking.
2018 年 4 月 14 日和 15 日，第六届儿科麻醉神经发育评估 (PANDA) 研讨会在哥伦比亚大学医学中心和纽约长老会摩根士丹利儿童医院举行。自 10 多年前成立以来，PANDA 研讨会一直是临床医生、研究人员和其他主要利益相关者聚集和审查与发育中大脑麻醉神经毒性相关的临床前和临床研究现状的重要论坛。它也是参与者从各种公共和私人监管机构获得洞察力和支持的重要场所。今年会议的目标包括评估当前知识的演变情况，努力制定共同的结果衡量标准，并为研究和政策制定未来方向。研讨会计划重点介绍了从临床前和临床研究结果到临床实践和决策更新等各个方面的前沿工作。
